TMR + CABG Trial Data Reveal Little About Procedure’s Efficacy – MCAC
This article was originally published in The Gray Sheet
Executive SummaryCMS should work with other HHS agencies to develop a new randomized trial comparing TMR + CABG to bypass alone, according to the Medicare Coverage Advisory Committee
You may also be interested in...
The lead investigator on the SYMPLICITY HTN-3 trial says sham-controlled trials are sometimes ethically necessary to prevent patients from undergoing ineffective treatments and warns there may be other medical devices on the market that are not as effective as previously thought.